EGFR and cancer: Mutations or overexpression of growth factor receptor (EGFR) or human growth factor receptor 2 (HER2), inactivating mutations in mTOR regulators gene such as TSC1 and TSC2, as well as the activating mutations in mTOR itself, are also detected across cancer types [14,15,16,17].